Utility of an intraoperative gamma probe in the surgical management of secondary or tertiary hyperparathyroidism

American Journal of Surgery

Volumn 196, Issue 1, 2008, Pages 13-18

  Jorna, Francisca H ^a   Jager, Pieter L ^a   Lemstra, Clara ^a   Wiggers, Theo ^a   Stegeman, Coen A ^a   Plukker, John T M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

99mTc sestamibi; Gamma probe; Parathyroidectomy; Secondary hyperparathyroidism

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; GAMMA PROBE; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; MINIMALLY INVASIVE SURGERY; PARATHYROID SCINTISCANNING; PARATHYROIDECTOMY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOACTIVITY; SECONDARY HYPERPARATHYROIDISM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL INSTRUMENT; SURGICAL PATIENT; TERTIARY HYPERPARATHYROIDISM; TISSUE SECTION;

GAMMA CAMERAS; GAMMA RAYS; HUMANS; HYPERPARATHYROIDISM; HYPERPARATHYROIDISM, SECONDARY; INTRAOPERATIVE PERIOD; PARATHYROID GLANDS; PARATHYROIDECTOMY; PROSPECTIVE STUDIES;

EID: 45349102495     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2007.05.059     Document Type: Article

References (33)

1. Moe S.M., and Drueke T.B. Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. Am J Nephrol 23 (2003) 369-379
2. Jorna F.H., Tobe T.J., Huisman R.M., et al. Early identification of risk factors for refractory secondary hyperparathyroidism in patients with long-term renal replacement therapy. Nephrol Dial Transplant 19 (2004) 1168-1173
3. Dotzenrath C., Cupisti K., Goretzki E., et al. Operative treatment of renal autonomous hyperparathyroidism: cause of persistent or recurrent disease in 304 patients. Langenbecks Arch Surg 387 (2003) 348-354
4. Gasparri G., Camandona M., Abbona G.C., et al. Secondary and tertiary hyperparathyroidism: causes of recurrent disease after 446 parathyroidectomies. Ann Surg 233 (2001) 65-69
5. Cattan P., Halimi B., Aidan K., et al. Reoperation for secondary uremic hyperparathyroidism: are technical difficulties influenced by initial surgical procedure?. Surgery 127 (2000) 562-565
6. Goldstein R.E., Martin W.H., and Richards K. Minimally invasive radioguided parathyroidectomy (MIRP). Minerva Chir 58 (2003) 269-279
7. Murphy C., and Norman J. The 20% rule: a simple, instantaneous radioactivity measurement defines cure and allows elimination of frozen sections and hormone assays during parathyroidectomy. Surgery 126 (1999) 1023-1028
8. Pons F., Torregrosa J.V., Vidal-Sicart S., et al. Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism. Eur J Nucl Med 24 (1997) 1494-1498
9. Pinero A., Rodriguez J.M., Ortiz S., et al. Relation of biochemical, cytologic, and morphologic parameters to the result of gammagraphy with technetium 99m sestamibi in primary hyperparathyroidism. Otolaryngol Head Neck Surg 122 (2000) 851-855
10. Olaizola I., Zingraff J., Heuguerot C., et al. [(99m)Tc]-sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations. Nephrol Dial Transplant 15 (2000) 1201-1206
11. Piga M., Bolasco P., Satta L., et al. Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 37 (1996) 565-569
12. Denham D.W., and Norman J. Cost-effectiveness of preoperative sestamibi scan for primary hyperparathyroidism is dependent solely upon the surgeon's choice of operative procedure. J Am Coll Surg 186 (1998) 293-305
13. Malberti F., Marcelli D., Conte F., et al. Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol 12 (2001) 1242-1248
14. Nichol P.F., Starling J.R., Mack E., et al. Long-term follow-up of patients with tertiary hyperparathyroidism treated by resection of a single or double adenoma. Ann Surg 235 (2002) 673-678
15. Hibi Y., Tominaga Y., Sato T., et al. Reoperation for renal hyperparathyroidism. World J Surg 26 (2002) 1301-1307
16. Chou F.F., Lee C.H., Chen H.Y., et al. Persistent and recurrent hyperparathyroidism after total parathyroidectomy with autotransplantation. Ann Surg 235 (2002) 99-104
17. LiVolsi V.A., and Hamilton R. Intraoperative assessment of parathyroid gland pathology. A common view from the surgeon and the pathologist. Am J Clin Pathol 102 (1994) 365-373
18. Johnson S.J., Sheffield E.A., and McNicol A.M. Best practice no 183. Examination of parathyroid gland specimens. J Clin Pathol 58 (2005) 338-342
19. Chen H., Mack E., and Starling J.R. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg 238 (2003) 332-337
20. Nichol P.F., Mack E., Bianco J., et al. Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidism. Surgery 134 (2003) 713-717
21. Ogi S., Fukumitsu N., Uchiyama M., et al. The usefulness of radio-guided surgery in secondary hyperparathyroidism. Ann Nucl Med 18 (2004) 69-71
22. McGreal G., Winter D.C., Sookhai S., et al. Minimally invasive, radioguided surgery for primary hyperparathyroidism. Ann Surg Oncol 8 (2001) 856-860
23. Mariani G., Gulec S.A., Rubello D., et al. Preoperative localization and radioguided parathyroid surgery. J Nucl Med 44 (2003) 1443-1458
24. Jaskowiak N.T., Sugg S.L., Helke J., et al. Pitfalls of intraoperative quick parathyroid hormone monitoring and gamma probe localization in surgery for primary hyperparathyroidism. Arch Surg 137 (2002) 659-668
25. Burkey S.H., Van Heerden J.A., Farley D.R., et al. Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism?. World J Surg 26 (2002) 914-920
26. Navarra G., Feggi L., Ascanelli S., et al. Role of radio-guided surgery in recurrent secondary hyperparathyroidism. Nephron 88 (2001) 36-38
27. Takeyama H., Shioya H., Mori Y., et al. Usefulness of radio-guided surgery using technetium-99m methoxyisobutylisonitrile for primary and secondary hyperparathyroidism. World J Surg 28 (2004) 576-582
28. Hindie E., Urena P., Jeanguillaume C., et al. Preoperative imaging of parathyroid glands with technetium-99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 353 (1999) 2200-2204
29. Neumann D.R., Esselstyn Jr. C.B., Madera A., et al. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Metab 83 (1998) 3867-3871
30. Chen H., Mack E., and Starling J.R. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg 238 (2003) 332-337
31. Fernandez K.L., Turer P., Spiegler E.J., et al. The use of sestamibi imaging in parathyroid hyperplasia. Clin Nucl Med 27 (2002) 865-867
32. Dackiw A.P., Sussman J.J., Fritsche Jr. H.A., et al. Relative contributions of technetium Tc 99m sestamibi scintigraphy, intraoperative gamma probe detection, and the rapid parathyroid hormone assay to the surgical management of hyperparathyroidism. Arch Surg 135 (2000) 550-555
33. Pattou F.N., Pellissier L.C., Noel C., et al. Supernumerary parathyroid glands: frequency and surgical significance in treatment of renal hyperparathyroidism. World J Surg 24 (2000) 1330-1334